Martin J Driscoll - Net Worth and Insider Trading
Martin J Driscoll Net Worth
The estimated net worth of Martin J Driscoll is at least $229,540 dollars as of 2024-12-28. Martin J Driscoll is the President and CEO of Spring Bank Pharmaceuticals Inc and owns about 47,425 shares of Spring Bank Pharmaceuticals Inc (SBPH) stock worth over $229,537. Martin J Driscoll is also the Director of MetaStat Inc and owns about 29,616 shares of MetaStat Inc (MTST) stock worth over $3. Details can be seen in Martin J Driscoll's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Martin J Driscoll has not made any transactions after 2020-11-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Martin J Driscoll
Martin J Driscoll Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Martin J Driscoll owns 3 companies in total, including Spring Bank Pharmaceuticals Inc (SBPH) , MetaStat Inc (MTST) , and F-star Therapeutics Inc (FSTX) .
Click here to see the complete history of Martin J Driscoll’s form 4 insider trades.
Insider Ownership Summary of Martin J Driscoll
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SBPH | Spring Bank Pharmaceuticals Inc | 2020-11-20 | director & President and CEO |
| MTST | MetaStat Inc | 2017-04-04 | director |
| FSTX | F-star Therapeutics Inc | 2016-05-05 | director & President and CEO |
Martin J Driscoll Latest Holdings Summary
Martin J Driscoll currently owns a total of 2 stocks. Among these stocks, Martin J Driscoll owns 47,425 shares of Spring Bank Pharmaceuticals Inc (SBPH) as of November 20, 2020, with a value of $229,537 and a weighting of 100%. Martin J Driscoll also owns 29,616 shares of MetaStat Inc (MTST) as of October 30, 2016, with a value of $3 and a weighting of 0%.
Latest Holdings of Martin J Driscoll
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SBPH | Spring Bank Pharmaceuticals Inc | 2020-11-20 | 47,425 | 4.84 | 229,537 |
| MTST | MetaStat Inc | 2016-10-30 | 29,616 | 0.00 | 3 |
Holding Weightings of Martin J Driscoll
Martin J Driscoll Form 4 Trading Tracker
According to the SEC Form 4 filings, Martin J Driscoll has made a total of 1 transactions in Spring Bank Pharmaceuticals Inc (SBPH) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Spring Bank Pharmaceuticals Inc is the sale of 175 shares on November 20, 2020, which brought Martin J Driscoll around $833.
According to the SEC Form 4 filings, Martin J Driscoll has made a total of 0 transactions in MetaStat Inc (MTST) over the past 5 years. The most-recent trade in MetaStat Inc is the acquisition of 28,342 shares on October 30, 2016, which cost Martin J Driscoll around $56,684.
Insider Trading History of Martin J Driscoll
- 1
Martin J Driscoll Trading Performance
GuruFocus tracks the stock performance after each of Martin J Driscoll's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Martin J Driscoll is -12.03%. GuruFocus also compares Martin J Driscoll's trading performance to market benchmark return within the same time period. The performance of stocks bought by Martin J Driscoll within 3 months outperforms 5 times out of 20 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Martin J Driscoll's insider trading performs compared to the benchmark.
Performance of Martin J Driscoll
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -0.48 | | | | | |
| Relative Return to S&P 500(%) | -1.17 | | | | | |
Martin J Driscoll Ownership Network
Martin J Driscoll Owned Company Details
What does Spring Bank Pharmaceuticals Inc do?
Who are the key executives at Spring Bank Pharmaceuticals Inc?
Martin J Driscoll is the director & President and CEO of Spring Bank Pharmaceuticals Inc. Other key executives at Spring Bank Pharmaceuticals Inc include VP of Finance and Treasurer Lori Firmani , Chief Scientific Officer Radhakrishnan P. Iyer , and General Counsel and Secretary Garrett Winslow .
Spring Bank Pharmaceuticals Inc (SBPH) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Spring Bank Pharmaceuticals Inc (SBPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Spring Bank Pharmaceuticals Inc (SBPH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Spring Bank Pharmaceuticals Inc (SBPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Spring Bank Pharmaceuticals Inc Insider Transactions
Martin J Driscoll Mailing Address
Above is the net worth, insider trading, and ownership report for Martin J Driscoll. You might contact Martin J Driscoll via mailing address: C/o Javelin Pharmaceuticals, Inc., 125 Cambridge Park Drive, Cambridge Ma 02140.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
